Apotheek Schoenaers SRL

Apotheek Schoenaers reported total assets of 345,167 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026).

Company number (CBE) 0456.059.455 · VAT BE0456059455
3830 Wellen
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 18 Sep 1995 (≈ 31 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek Schoenaers shows with a free account.

See the score
Profile
SRL since 1995
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−6,899 €
Equity25,765 €
Cash11,319 €
EBITDA11,816 €
Total assets345,167 €
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity -21 % Total assets -8 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek Schoenaers's annual accounts

20252024202320222021
Net result−6,899 €
Equity25,765 €
Cash11,319 €
EBITDA11,816 €
Total assets345,167 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 24 Jul 2026
  • Year ended 31 Dec 2024filed on 19 Jun 2025
  • Year ended 31 Dec 2023filed on 16 Jul 2024
  • Year ended 31 Dec 2022filed on 11 Aug 2023
  • Year ended 31 Dec 2021filed on 01 Aug 2022

Apotheek Schoenaers's financial analysis

Management and control of Apotheek Schoenaers

2 active director(s) in the register.

Apotheek Schoenaers's shareholders and holdings →

Apotheek Schoenaers's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0456.059.455
VAT number
BE0456059455
Peppol
Registered · 0208:0456059455 · as of 10 Nov 2026
Legal form
SRL
Incorporated
18 Sep 1995
Registered office
3830 Wellen
Latest accounts
2025 · filed on 24 Jul 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek Schoenaers (SRL) has been based in Wellen since 1995, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 6,899 € and equity of 25,765 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Apotheek Schoenaers

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek Schoenaers

What is the revenue of Apotheek Schoenaers?

Apotheek Schoenaers files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Apotheek Schoenaers?

In Belgium, the VAT number is the company number prefixed with BE: BE0456059455 for Apotheek Schoenaers, if the company is VAT-registered. Its company number (CBE) is 0456.059.455.

Where is the registered office of Apotheek Schoenaers?

According to the CBE register, the registered office of Apotheek Schoenaers is in 3830 Wellen.

What is the equity of Apotheek Schoenaers?

At the close of the 2025 financial year, the equity of Apotheek Schoenaers amounts to 25,765 €, a solvency of 7.5% of total assets.

Who manages Apotheek Schoenaers?

The register lists 2 active mandates at Apotheek Schoenaers. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek Schoenaers

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 07 Aug 2026

No credit card, no commitment.

What each plan unlocks →